Clinical Trial Update: Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the combination of Lucentis (ranibizumab) and Visudyne (verteporfin) for age-related macular degeneration was terminated. Results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Lucentis (ranibizumab)
• Visudyne (verteporfin)

Snippet

Sponsor: David M. Brown, M.D. | Conditions: Age-Related Macular Degeneration | Phase 4 | Status: TERMINATED | Results posted: 2016-03-04